- Home
- HURA vs FCAP Comparison
HURA vs FCAP Comparison
Compare HURA & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURA
- FCAP
- Stock Information
- Founded
- HURA 2009
- FCAP 1891
- Country
- HURA United States
- FCAP United States
- Employees
- HURA N/A
- FCAP N/A
- Industry
- HURA
- FCAP Savings Institutions
- Sector
- HURA
- FCAP Finance
- Exchange
- HURA Nasdaq
- FCAP Nasdaq
- Market Cap
- HURA 126.1M
- FCAP 125.9M
- IPO Year
- HURA N/A
- FCAP 1999
- Fundamental
- Price
- HURA $2.43
- FCAP $44.29
- Analyst Decision
- HURA Strong Buy
- FCAP
- Analyst Count
- HURA 2
- FCAP 0
- Target Price
- HURA $11.50
- FCAP N/A
- AVG Volume (30 Days)
- HURA 237.9K
- FCAP 3.8K
- Earning Date
- HURA 11-13-2025
- FCAP 10-24-2025
- Dividend Yield
- HURA N/A
- FCAP 2.62%
- EPS Growth
- HURA N/A
- FCAP 9.31
- EPS
- HURA N/A
- FCAP 3.93
- Revenue
- HURA N/A
- FCAP $44,673,000.00
- Revenue This Year
- HURA N/A
- FCAP N/A
- Revenue Next Year
- HURA N/A
- FCAP N/A
- P/E Ratio
- HURA N/A
- FCAP $11.38
- Revenue Growth
- HURA N/A
- FCAP 9.48
- 52 Week Low
- HURA $1.80
- FCAP $28.50
- 52 Week High
- HURA $8.40
- FCAP $53.85
- Technical
- Relative Strength Index (RSI)
- HURA 43.35
- FCAP 66.53
- Support Level
- HURA $2.35
- FCAP $42.77
- Resistance Level
- HURA $2.64
- FCAP $44.04
- Average True Range (ATR)
- HURA 0.17
- FCAP 0.68
- MACD
- HURA -0.03
- FCAP 0.26
- Stochastic Oscillator
- HURA 22.03
- FCAP 83.52
About HURA TuHURA Biosciences Inc. Common Stock
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
About FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.